BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35141721)

  • 1. Stability of Olmesartan Medoxomil Extemporaneous Suspensions.
    Bhattarai P; McPherson T; Nieto M; Kolling WM
    J Pharm Technol; 2022 Feb; 38(1):3-9. PubMed ID: 35141721
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability and Beyond-Use Date of a Compounded Thioguanine Suspension.
    Gilda SS; Kolling WM; Nieto M; McPherson T
    J Pharm Technol; 2021 Feb; 37(1):23-29. PubMed ID: 34752544
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of a pyrimethamine suspension compounded from bulk powder.
    Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
    Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
    Int J Pharm Compd; 2020; 24(5):413-419. PubMed ID: 32886640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(2):169-175. PubMed ID: 33798117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Miller V; Morris TC; Graves RA
    Int J Pharm Compd; 2019; 23(1):70-76. PubMed ID: 30668538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of an extemporaneous alcohol-free melatonin suspension.
    Johnson CE; Cober MP; Thome T; Rouse E
    Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2023; 27(4):330-339. PubMed ID: 37595175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Morris TC; Graves RA
    Int J Pharm Compd; 2019; 23(2):157-162. PubMed ID: 31085781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(5):431-439. PubMed ID: 34623970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
    Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
    Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
    Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2022; 26(4):342-351. PubMed ID: 35820140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of propranolol hydrochloride suspension compounded from tablets.
    Henry DW; Repta AJ; Smith FM; White SJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1492-5. PubMed ID: 3728486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
    Peacock GF; Sauvageot J; Hill A; Killian A
    Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.